Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders

Harada, Takayuki; Tsutomi, Hiroshi; Mori, Rintaro; Wilson, David B.

doi:10.1002/14651858.cd011315

Cited by 5 publications

(8 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…82 Others reported that brief cognitive behavioral therapy resulted in significant reductions in the frequency of methamphetamine use, MUD severity, and number of days of methamphetamine use at weeks 4 and 12, 83 findings consistent with those in a systematic review that found weak evidence for an increased percentage of abstinent days (during a 90-day period) and reduced MUD symptoms. 84 Similarly, behavioral activation, which aims to maximize activities that are not drug-related but are positively valued by the individual, was associated with abstinence of alcohol, tobacco, opioid, and methamphetamine use in 7 of the 8 reviewed studies and with improved depression over time in 6 studies. 85 Finally, several studies demonstrated a beneficial association of exercise with reducing MUD symptoms.…”

Section: Interventionsmentioning

confidence: 99%

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder

2020

View full text Add to dashboard Cite

In the wake of the opioid crisis, methamphetamine has reemerged as a challenge to mental health clinicians and researchers alike. Methamphetamine is now available in different forms such as ice, powder, and pills, with different pharmacokinetic characteristics that make them popular among certain types of individuals. 1 Recent seizure data suggest that methamphetamine production and trafficking are spreading into new areas of the globe. 2 According to the Automation of Reports and Consolidated Orders System, methamphetamine consumption increased 4-fold between 2015 and 2016 and total stimulant use doubled in the last decade. 3 From 2011 through 2016, the age-adjusted rate of drug overdose deaths involving methamphetamine more than tripled. 4 Moreover, drug overdose deaths involving cocaine, amphetamines, or both substances combined increased 42.4% from 12 122 in 2015 to 17 258 in 2016. 5 Based on the most recent data from the National Survey on Drug Use and Health, 6 the 12-month prevalence of individuals aged 12 years or older reporting methamphetamine use has increased by 195% from its low in 2010 to 2018 (Figure 1), and it is estimated that 1.86 million Americans used methamphetamine in 2018. These numbers underline the importance of paying attention to the possibility of the next substance use crisis. However, whereas opioid use disorder can be treated pharmacologically 7 and behaviorally, 8 there are significant challenges for the treatment of methamphetamine use disorder (MUD). This review focuses on 3 specific aspects of MUD. First, the neurobiology of methamphetamine is more complex than the traditional view of it as a monoaminergic modulator. Second, the clinical presentation is not limited to the symptoms associated with use disorder but extend to medical presentations, most notably the cardiovascular and cerebrovascular systems. Third, pharmacologic interventions focused on modulating the monoaminergic pathways have largely failed, and new pharmacologic approaches are necessary to focus on novel treatment targets. In the final section, several suggestions will be proposed for both clinicians and researchers to advance the understanding of MUD. Biological Pathways, Neural Basis, and CognitionMethamphetamine has been conceptualized primarily as a releaser of dopamine, serotonin, noradrenaline, and adrenaline from nerve terminals in the central and peripheral nervous system, 9 which occurs via several different mechanisms, including (1) redistributing catecholamines from synaptic vesicles to the cytosol, (2) reversing the plasma membrane transport of neurotransmitters, (3) blocking the activity of monoamine transporters, (4) decreasing the expression of dopamine transporters at the cell surface, (5) inhibiting monoamine oxidase activity, and (6) increasing the activity and IMPORTANCE The prevalence of and mortality associated with methamphetamine use has doubled during the past 10 years. There is evidence suggesting that methamphetamine use disorder could be the next substance use crisis in the United ...

show abstract

Section: Interventionsmentioning

confidence: 99%

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder

2020

View full text Add to dashboard Cite

show abstract

“…There is limited evidence supporting the efficacy of specific pharmacological or behavioral treatments for ATS use disorder (Brensilver, Heinzerling, and Shoptaw 2013;Harada et al 2014), and there are no specific interventions provided to individuals with ATS use by the government, NGOs, or treatment providers in Malaysia. Individuals who are found with evidence of ATS use or possession can be detained by the police, charged, and fined or placed under community supervision with the NADA for a period of two years.…”

mentioning

confidence: 99%

Emerging Drug Use Trends in Kelantan, Malaysia

Desrosiers

Chooi

Zaharim

et al. 2016

Journal of Psychoactive Drugs

View full text Add to dashboard Cite

The primarily rural and agrarian Kelantan province of Malaysia has high rates of drug use and is characterized by unique sociocultural factors. Combining qualitative and ethnographic methods, we investigated drug use and treatment needs of people who use drugs (PWUD) in rural areas of Kelantan. In February 2014, field visits, participant observation, and focus group discussions (FGDs) with 27 active PWUD were conducted in rural areas surrounding the capital city of Kelantan. The findings indicate a high prevalence of opiate and amphetamine type stimulants (ATS) use in these areas. FGD participants reported initiating drug use at early ages due to peer influences, to relieve boredom, to cope with problems, and a high saturation of villages with other PWUD was reported as a major contributor to their own continued drug use. They reported a trend of drug use initiation at younger ages and increased drug use among females. Participants were interested in treatment; however, their limited knowledge about treatment options and perceived limited availability of services were barriers to treatment seeking. Easy access to drugs, primarily from Thailand and facilitated by the use of mobile phones, resulted in an expanding prevalence of drug use that underscores the need to bolster education and prevention efforts and accessibility of treatment services in Kelantan.

show abstract

“…Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)use disorders 129 Harad T 2010-2015 Systematic with metaanalysis Studies do not include withdrawal intervention and only address dependence.…”

Section: Commentary On Review Evidence Gradementioning

confidence: 99%

“…Various systematic reviews examined the efficacy of psychosocial interventions for the treatment of cocaine dependence. 129,133,153 Cocaine withdrawal was not a treatment outcome for any of the studies included in these reviews. Overall, psychosocial interventions appeared to decrease the dropout rates and contribute to a longer period of abstinence compared to the treatment as usual option.…”

Section: Psychosocial Interventionsmentioning

confidence: 99%

“…Existing research appears to be focusing on the impact of long term MDMA use on cognitive function and memory. 164 Two reviews on the psychosocial interventions for stimulant use disorders included MDMA in their scope 129,153 but MDMA withdrawal was not one of the outcomes in any of the studies that were included in the review. Overall, both of these papers concluded that psychosocial interventions improved the retention rates in treatment as well as abstinence rates, but long-term effectiveness of these interventions was not clear.…”

Section: Psychosocial Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Management of withdrawal from alcohol and other drugs

Lintzeris¹,

Sunjic²,

Demirkol³

et al. 2019

View full text Add to dashboard Cite

This review on management of withdrawal from alcohol and other drugs aimed to identify: the most effective practices; which withdrawal strategies are most effective in improving treatment outcomes for special population groups; and the differential effects of withdrawal management approaches by setting. The review identified the importance of a ‘package of care’ which includes psychosocial, physical and pharmacological interventions, and these should be incorporated into all withdrawal services. The challenge is to ensure that effective services are available, patient-centred, evidence-based and efficient. The review suggests that a re- examination of the NSW approach is needed with more emphasis on ambulatory withdrawal services. The review also highlights a need for more research into interventions for special populations including older people.

show abstract

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders

Abstract: Background Objectives Search methods Selection criteria Data collection and analysis Main results Authors' conclusions Plain language summary [Summary title] [Summary text]Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders 2 / 10

Cited by 5 publications

References 18 publications

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder

Emerging Drug Use Trends in Kelantan, Malaysia

Management of withdrawal from alcohol and other drugs

Contact Info

Product

Resources

About